Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells
Most studies on genetic engineering technologies for cancer immunotherapy based on allogeneic donors have focused on adaptive immunity. However, the main limitation of such approaches is that they can lead to severe graft-versus-host disease (GvHD). An alternative approach would bolster innate immun...
Main Authors: | Fabio Morandi, Mahboubeh Yazdanifar, Claudia Cocco, Alice Bertaina, Irma Airoldi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/8/1757 |
Similar Items
-
γδ T Cells: The Ideal Tool for Cancer Immunotherapy
by: Mahboubeh Yazdanifar, et al.
Published: (2020-05-01) -
Graft-versus-Host Disease Modulation by Innate T Cells
by: Ying Fang, et al.
Published: (2023-02-01) -
A Simple and Robust Single-Step Method for CAR-Vδ1 γδT Cell Expansion and Transduction for Cancer Immunotherapy
by: Gabrielle M. Ferry, et al.
Published: (2022-05-01) -
γδ T cells: a sparkling star for clinical immunotherapy
by: Jiamian Zheng, et al.
Published: (2022-08-01) -
Osteoclasts and Probiotics Mediate Significant Expansion, Functional Activation and Supercharging in NK, γδ T, and CD3+ T Cells: Use in Cancer Immunotherapy
by: Kawaljit Kaur, et al.
Published: (2024-01-01)